OncoDNA, IBBL Team to Bring Sequencing-based Tests to Luxembourg Physicians | GenomeWeb

NEW YORK (GenomeWeb News) – OncoDNA today said that it will collaborate with the Integrated BioBank of Luxembourg to provide physicians in Luxembourg with access to next-generation sequencing-based testing for cancer.

Specifically, OncoDNA was chosen by IBBL as a preferred supplier of molecular diagnostics for lung cancer. The Belgium-based firm will provide its OncoDEEP Dx cancer panel, which includes 50 genes and runs on the Ion Torrent PGM, under the alliance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.